Boston Scientific Corporation (BSX)

53,65 -0,32 (-0,59%) Ab 10:05AM EDT. Markt geöffnet.

Boston Scientific Corporation

300 Boston Scientific Way
Marlborough, MA 01752-1234
United States
508 683 4000
https://www.bostonscientific.com

Sektor(en): Healthcare
Branche: Medical Devices
Vollzeitmitarbeiter: 45.000

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Michael F. Mahoney	Chairman, Pres & CEO	3,77M	15,78M	1965
Mr. Daniel J. Brennan	Exec. VP & CFO	1,69M	1,96M	1966
Mr. Joseph M. Fitzgerald	Exec. VP & Group Pres of Cardiology	1,53M	3,2M	1964
Mr. Jeffrey B. Mirviss	Exec. VP & Pres of Peripheral Interventions	1,15M	977,61k	1966
Mr. Arthur Crosswell Butcher	Exec. VP and Group Pres of MedSurg & Asia Pacific	1,4M	155,24k	1971
Mr. John Bradley Sorenson	Exec. VP of Global Operations	N/A	N/A	1968
Mr. Jonathan R Monson	Sr. VP, Global Controller & Chief Accounting Officer	N/A	N/A	N/A
Ms. Jodi Euerle Eddy	Sr. VP and Chief Information & Digital Officer	N/A	N/A	1973
Ms. Susan Vissers Lisa	VP of Investor Relations	N/A	N/A	1969
Mr. Vance R. Brown	Sr. VP, Gen. Counsel & Corp. Sec.	N/A	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2022 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through MedSurg and Cardiovascular segments. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, that uses in the treatment of coronary artery disease and aortic valve conditions. Further, it provides stents, balloon catheters, guidewires, atherectomy, and thrombectomy systems to treat arterial and venous diseases; and peripheral embolization devices, radioactive microspheres, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Corporate Governance

Boston Scientific Corporations ISS Governance QualityScore, Stand 1. September 2023, lautet 9. Die grundlegenden Scores sind Audit: 10, Vorstand: 9, Shareholderrechte: 8, Kompensation: 7.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.